These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
|
|
|||||||
(Address of principal executive offices) | (Zip code) |
Title of each class | Trading Symbol (s) | Name of each exchange on which registered | ||||||
|
|
New York Stock Exchange (
|
|
þ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | ||||||||||||
Smaller reporting company |
|
Emerging growth company |
|
Page | ||||||||
Item 5.
|
Other Information
|
|||||||
Three Months Ended | ||||||||||||||
(In millions, except per share amounts) |
April 1,
2023 |
April 2,
2022 |
||||||||||||
Revenues | ||||||||||||||
Manufacturing product revenues | $ |
|
$ |
|
||||||||||
Manufacturing service revenues |
|
|
||||||||||||
Finance revenues |
|
|
||||||||||||
Total revenues |
|
|
||||||||||||
Costs, expenses and other | ||||||||||||||
Cost of products sold |
|
|
||||||||||||
Cost of services sold |
|
|
||||||||||||
Selling and administrative expense |
|
|
||||||||||||
Interest expense, net |
|
|
||||||||||||
Non-service components of pension and postretirement income, net |
(
|
(
|
||||||||||||
Total costs, expenses and other |
|
|
||||||||||||
Income before income taxes |
|
|
||||||||||||
Income tax expense |
|
|
||||||||||||
Net income | $ |
|
$ |
|
||||||||||
Earnings per share | ||||||||||||||
Basic | $ |
|
$ |
|
||||||||||
Diluted | $ |
|
$ |
|
||||||||||
Three Months Ended | ||||||||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||||||||
Net income | $ |
|
$ |
|
||||||||||
Other comprehensive income, net of tax | ||||||||||||||
Pension and postretirement benefits adjustments, net of reclassifications |
|
|
||||||||||||
Foreign currency translation adjustments |
|
(
|
||||||||||||
Deferred gains (losses) on hedge contracts, net of reclassifications |
(
|
|
||||||||||||
Other comprehensive income |
|
|
||||||||||||
Comprehensive income | $ |
|
$ |
|
(Dollars in millions) |
April 1,
2023 |
December 31,
2022 |
||||||
Assets | ||||||||
Manufacturing group | ||||||||
Cash and equivalents | $ |
|
$ |
|
||||
Accounts receivable, net |
|
|
||||||
Inventories |
|
|
||||||
Other current assets |
|
|
||||||
Total current assets |
|
|
||||||
Property, plant and equipment, less accumulated depreciation
and amortization of $
|
|
|
||||||
Goodwill |
|
|
||||||
Other assets |
|
|
||||||
Total Manufacturing group assets |
|
|
||||||
Finance group | ||||||||
Cash and equivalents |
|
|
||||||
Finance receivables, net |
|
|
||||||
Other assets |
|
|
||||||
Total Finance group assets |
|
|
||||||
Total assets | $ |
|
$ |
|
||||
Liabilities and shareholders’ equity | ||||||||
Liabilities | ||||||||
Manufacturing group | ||||||||
Current portion of long-term debt | $ |
|
$ |
|
||||
Accounts payable |
|
|
||||||
Other current liabilities |
|
|
||||||
Total current liabilities |
|
|
||||||
Other liabilities |
|
|
||||||
Long-term debt |
|
|
||||||
Total Manufacturing group liabilities |
|
|
||||||
Finance group | ||||||||
Other liabilities |
|
|
||||||
Debt |
|
|
||||||
Total Finance group liabilities |
|
|
||||||
Total liabilities |
|
|
||||||
Shareholders’ equity | ||||||||
Common stock |
|
|
||||||
Capital surplus |
|
|
||||||
Treasury stock |
(
|
(
|
||||||
Retained earnings |
|
|
||||||
Accumulated other comprehensive loss |
(
|
(
|
||||||
Total shareholders’ equity |
|
|
||||||
Total liabilities and shareholders’ equity | $ |
|
$ |
|
||||
Common shares outstanding (in thousands) |
|
|
Consolidated | ||||||||
(In millions) | 2023 | 2022 | ||||||
Cash flows from operating activities | ||||||||
Net income | $ |
|
$ |
|
||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
Non-cash items: | ||||||||
Depreciation and amortization |
|
|
||||||
Deferred income taxes |
(
|
(
|
||||||
Other, net |
|
|
||||||
Changes in assets and liabilities: | ||||||||
Accounts receivable, net |
(
|
|
||||||
Inventories |
(
|
(
|
||||||
Other assets |
|
(
|
||||||
Accounts payable |
|
|
||||||
Other liabilities |
(
|
|
||||||
Income taxes, net |
|
|
||||||
Pension, net |
(
|
(
|
||||||
Captive finance receivables, net |
|
|
||||||
Other operating activities, net |
|
|
||||||
Net cash provided by operating activities |
|
|
||||||
Cash flows from investing activities | ||||||||
Capital expenditures |
(
|
(
|
||||||
Net proceeds from corporate-owned life insurance policies |
|
|
||||||
Proceeds from sale of property, plant and equipment |
|
|
||||||
Finance receivables repaid |
|
|
||||||
Other investing activities, net |
|
|
||||||
Net cash provided by (used in) investing activities |
(
|
|
||||||
Cash flows from financing activities | ||||||||
Principal payments on long-term debt and nonrecourse debt |
(
|
(
|
||||||
Purchases of Textron common stock |
(
|
(
|
||||||
Dividends paid |
(
|
(
|
||||||
Proceeds from options exercised |
|
|
||||||
Other financing activities, net |
(
|
(
|
||||||
Net cash used in financing activities |
(
|
(
|
||||||
Effect of exchange rate changes on cash and equivalents |
|
(
|
||||||
Net increase (decrease) in cash and equivalents |
(
|
|
||||||
Cash and equivalents at beginning of period |
|
|
||||||
Cash and equivalents at end of period | $ |
|
$ |
|
Manufacturing Group | Finance Group | |||||||||||||
(In millions) | 2023 | 2022 | 2023 | 2022 | ||||||||||
Cash flows from operating activities | ||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
||||||
Adjustments to reconcile net income to net cash
provided by (used in) operating activities: |
||||||||||||||
Non-cash items: | ||||||||||||||
Depreciation and amortization |
|
|
|
|
||||||||||
Deferred income taxes |
(
|
(
|
|
(
|
||||||||||
Other, net |
|
|
(
|
(
|
||||||||||
Changes in assets and liabilities: | ||||||||||||||
Accounts receivable, net |
(
|
|
|
|
||||||||||
Inventories |
(
|
(
|
|
|
||||||||||
Other assets |
|
(
|
|
|
||||||||||
Accounts payable |
|
|
|
|
||||||||||
Other liabilities |
(
|
|
(
|
(
|
||||||||||
Income taxes, net |
|
|
|
|
||||||||||
Pension, net |
(
|
(
|
|
|
||||||||||
Other operating activities, net |
|
|
|
|
||||||||||
Net cash provided by (used in) operating activities |
|
|
|
(
|
||||||||||
Cash flows from investing activities | ||||||||||||||
Capital expenditures |
(
|
(
|
|
|
||||||||||
Net proceeds from corporate-owned life insurance policies |
|
|
|
|
||||||||||
Proceeds from sale of property, plant and equipment |
|
|
|
|
||||||||||
Finance receivables repaid |
|
|
|
|
||||||||||
Finance receivables originated |
|
|
(
|
(
|
||||||||||
Other investing activities, net |
|
|
|
|
||||||||||
Net cash provided by (used in) investing activities |
(
|
(
|
|
|
||||||||||
Cash flows from financing activities | ||||||||||||||
Principal payments on long-term debt and nonrecourse debt |
(
|
(
|
(
|
(
|
||||||||||
Purchases of Textron common stock |
(
|
(
|
|
|
||||||||||
Dividends paid |
(
|
(
|
|
|
||||||||||
Proceeds from options exercised |
|
|
|
|
||||||||||
Other financing activities, net |
(
|
(
|
|
|
||||||||||
Net cash used in financing activities |
(
|
(
|
(
|
(
|
||||||||||
Effect of exchange rate changes on cash and equivalents |
|
(
|
|
|
||||||||||
Net increase (decrease) in cash and equivalents |
(
|
|
|
(
|
||||||||||
Cash and equivalents at beginning of period |
|
|
|
|
||||||||||
Cash and equivalents at end of period | $ |
|
$ |
|
$ |
|
$ |
|
(In millions) |
April 1,
2023 |
December 31,
2022 |
||||||
Commercial | $ |
|
$ |
|
||||
U.S. Government contracts |
|
|
||||||
|
|
|||||||
Allowance for credit losses |
(
|
(
|
||||||
Total accounts receivable, net | $ |
|
$ |
|
(In millions) |
April 1,
2023 |
December 31,
2022 |
||||||
Finance receivables | $ |
|
$ |
|
||||
Allowance for credit losses |
(
|
(
|
||||||
Total finance receivables, net | $ |
|
$ |
|
(Dollars in millions) |
April 1,
2023 |
December 31,
2022 |
||||||
Performing | $ |
|
$ |
|
||||
Watchlist |
|
|
||||||
Nonaccrual |
|
|
||||||
Nonaccrual as a percentage of finance receivables |
|
|
||||||
Current and less than 31 days past due | $ |
|
$ |
|
||||
31-60 days past due |
|
|
||||||
61-90 days past due |
|
|
||||||
Over 90 days past due |
|
|
||||||
60+ days contractual delinquency as a percentage of finance receivables |
|
|
(In millions) |
April 1,
2023 |
December 31,
2022 |
||||||
Finance receivables evaluated collectively | $ |
|
$ |
|
||||
Finance receivables evaluated individually |
|
|
||||||
Allowance for credit losses based on collective evaluation |
|
|
||||||
Allowance for credit losses based on individual evaluation |
|
|
||||||
Impaired finance receivables with specific allowance for credit losses | $ |
|
$ |
|
||||
Impaired finance receivables with no specific allowance for credit losses |
|
|
||||||
Unpaid principal balance of impaired finance receivables |
|
|
||||||
Allowance for credit losses on impaired finance receivables |
|
|
||||||
Average recorded investment of impaired finance receivables |
|
|
(In millions) |
April 1,
2023 |
December 31,
2022 |
||||||
Finished goods | $ |
|
$ |
|
||||
Work in process |
|
|
||||||
Raw materials and components |
|
|
||||||
Total inventories | $ |
|
$ |
|
Three Months Ended | ||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||
Beginning of period | $ |
|
$ |
|
||||
Provision |
|
|
||||||
Settlements |
(
|
(
|
||||||
Adjustments* |
|
|
||||||
End of period | $ |
|
$ |
|
(Dollars in millions) |
April 1,
2023 |
December 31,
2022 |
||||||
Other assets | $ |
|
$ |
|
||||
Other current liabilities |
|
|
||||||
Other liabilities |
|
|
||||||
Weighted-average remaining lease term (in years) |
|
|
||||||
Weighted-average discount rate |
|
|
April 1, 2023 | December 31, 2022 | |||||||||||||
Carrying | Estimated | Carrying | Estimated | |||||||||||
(In millions) | Value | Fair Value | Value | Fair Value | ||||||||||
Manufacturing group | ||||||||||||||
Debt, excluding leases | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||
Finance group | ||||||||||||||
Finance receivables, excluding leases |
|
|
|
|
||||||||||
Debt |
(
|
(
|
(
|
(
|
(In millions) |
Common
Stock |
Capital
Surplus |
Treasury
Stock |
Retained
Earnings |
Accumulated
Other Comprehensive Loss |
Total
Shareholders' Equity |
||||||||||||||
Three months ended April 1, 2023 | ||||||||||||||||||||
Beginning of period | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||
Net income | — | — | — |
|
— |
|
||||||||||||||
Other comprehensive income | — | — | — | — |
|
|
||||||||||||||
Share-based compensation activity | — |
|
— | — | — |
|
||||||||||||||
Dividends declared | — | — | — |
(
|
— |
(
|
||||||||||||||
Purchases of common stock, including excise tax* | — | — |
(
|
— | — |
(
|
||||||||||||||
End of period | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||
Three months ended April 2, 2022 | ||||||||||||||||||||
Beginning of period | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||
Net income | — | — | — |
|
— |
|
||||||||||||||
Other comprehensive income | — | — | — | — |
|
|
||||||||||||||
Share-based compensation activity | — |
|
— | — | — |
|
||||||||||||||
Dividends declared | — | — | — |
(
|
— |
(
|
||||||||||||||
Purchases of common stock | — | — |
(
|
— | — |
(
|
||||||||||||||
End of period | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
Three Months Ended | ||||||||||||||
(In thousands) |
April 1,
2023 |
April 2,
2022 |
||||||||||||
Basic weighted-average shares outstanding |
|
|
||||||||||||
Dilutive effect of stock options |
|
|
||||||||||||
Diluted weighted-average shares outstanding |
|
|
(In millions) |
Pension and
Postretirement Benefits Adjustments |
Foreign
Currency Translation Adjustments |
Deferred
Gains (Losses) on Hedge Contracts |
Accumulated
Other Comprehensive Loss |
||||||||||
Balance at December 31, 2022 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||
Other comprehensive income before reclassifications |
|
|
(
|
|
||||||||||
Reclassified from Accumulated other comprehensive loss |
|
|
|
|
||||||||||
Balance at April 1, 2023 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||
Balance at January 1, 2022 | $ |
(
|
$ |
|
$ |
|
$ |
(
|
||||||
Other comprehensive loss before reclassifications |
|
(
|
|
(
|
||||||||||
Reclassified from Accumulated other comprehensive loss |
|
|
|
|
||||||||||
Balance at April 2, 2022 | $ |
(
|
$ |
(
|
$ |
|
$ |
(
|
April 1, 2023 | April 2, 2022 | |||||||||||||||||||
(In millions) |
Pre-Tax
Amount |
Tax
(Expense) Benefit |
After-tax
Amount |
Pre-Tax
Amount |
Tax
(Expense) Benefit |
After-tax
Amount |
||||||||||||||
Three Months Ended | ||||||||||||||||||||
Pension and postretirement benefits adjustments: | ||||||||||||||||||||
Amortization of net actuarial (gain) loss* | $ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||
Amortization of prior service cost* |
|
(
|
|
|
(
|
|
||||||||||||||
Pension and postretirement benefits adjustments, net |
|
|
|
|
(
|
|
||||||||||||||
Foreign currency translation adjustments |
|
|
|
(
|
|
(
|
||||||||||||||
Deferred gains (losses) on hedge contracts: | ||||||||||||||||||||
Current deferrals |
(
|
|
(
|
|
(
|
|
||||||||||||||
Reclassification adjustments |
|
(
|
|
|
|
|
||||||||||||||
Deferred gains (losses) on hedge contracts, net |
(
|
|
(
|
|
(
|
|
||||||||||||||
Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
Three Months Ended | ||||||||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||||||||
Revenues | ||||||||||||||
Textron Aviation | $ |
|
$ |
|
||||||||||
Bell |
|
|
||||||||||||
Textron Systems |
|
|
||||||||||||
Industrial |
|
|
||||||||||||
Textron eAviation |
|
|
||||||||||||
Finance |
|
|
||||||||||||
Total revenues | $ |
|
$ |
|
||||||||||
Segment Profit | ||||||||||||||
Textron Aviation | $ |
|
$ |
|
||||||||||
Bell |
|
|
||||||||||||
Textron Systems |
|
|
||||||||||||
Industrial |
|
|
||||||||||||
Textron eAviation |
(
|
|
||||||||||||
Finance |
|
|
||||||||||||
Segment profit |
|
|
||||||||||||
Corporate expenses and other, net |
(
|
(
|
||||||||||||
Interest expense, net for Manufacturing group |
(
|
(
|
||||||||||||
LIFO inventory provision |
(
|
(
|
||||||||||||
Intangible asset amortization |
(
|
(
|
||||||||||||
Non-service components of pension and postretirement income, net |
|
|
||||||||||||
Income before income taxes | $ |
|
$ |
|
Three Months Ended | ||||||||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||||||||
Aircraft | $ |
|
$ |
|
||||||||||
Aftermarket parts and services |
|
|
||||||||||||
Textron Aviation |
|
|
||||||||||||
Military aircraft and support programs |
|
|
||||||||||||
Commercial helicopters, parts and services |
|
|
||||||||||||
Bell |
|
|
||||||||||||
Textron Systems |
|
|
||||||||||||
Fuel systems and functional components |
|
|
||||||||||||
Specialized vehicles |
|
|
||||||||||||
Industrial |
|
|
||||||||||||
Textron eAviation |
|
|
||||||||||||
Finance |
|
|
||||||||||||
Total revenues | $ |
|
$ |
|
(In millions) |
Textron
Aviation |
Bell |
Textron
Systems |
Industrial | Textron eAviation | Finance | Total | ||||||||||||||||
Three months ended April 1, 2023 | |||||||||||||||||||||||
Customer type: | |||||||||||||||||||||||
Commercial | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
U.S. Government |
|
|
|
|
|
|
|
||||||||||||||||
Total revenues | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Geographic location: | |||||||||||||||||||||||
United States | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Europe |
|
|
|
|
|
|
|
||||||||||||||||
Other international |
|
|
|
|
|
|
|
||||||||||||||||
Total revenues | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Three months ended April 2, 2022 | |||||||||||||||||||||||
Customer type: | |||||||||||||||||||||||
Commercial | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
U.S. Government |
|
|
|
|
|
|
|
||||||||||||||||
Total revenues | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Geographic location: | |||||||||||||||||||||||
United States | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Europe |
|
|
|
|
|
|
|
||||||||||||||||
Other international |
|
|
|
|
|
|
|
||||||||||||||||
Total revenues | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
Three Months Ended | ||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||
Compensation expense | $ |
|
$ |
|
||||
Income tax benefit |
(
|
(
|
||||||
Total compensation expense included in net income | $ |
|
$ |
|
March 1, 2023 | March 1, 2022 | |||||||
Fair value of options at grant date | $ |
|
$ |
|
||||
Dividend yield |
|
|
||||||
Expected volatility |
|
|
||||||
Risk-free interest rate |
|
|
||||||
Expected term (in years) |
|
|
(Options in thousands) |
Number of
Options |
Weighted-
Average Exercise Price |
||||||
Outstanding at December 31, 2022 |
|
$ |
|
|||||
Granted |
|
|
||||||
Exercised |
(
|
(
|
||||||
Forfeited or expired |
(
|
(
|
||||||
Outstanding at April 1, 2023 |
|
$ |
|
|||||
Exercisable at April 1, 2023 |
|
$ |
|
Units Payable in Stock | Units Payable in Cash | ||||||||||||||||
(Shares/Units in thousands) |
Number of
Shares |
Weighted-
Average Grant Date Fair Value |
Number of
Units |
Weighted-
Average Grant Date Fair Value |
|||||||||||||
Outstanding at December 31, 2022, nonvested |
|
$ |
|
|
$ |
|
|||||||||||
Granted |
|
|
|
|
|||||||||||||
Vested |
(
|
(
|
(
|
(
|
|||||||||||||
Forfeited |
|
|
(
|
(
|
|||||||||||||
Outstanding at April 1, 2023, nonvested |
|
$ |
|
|
$ |
|
Three Months Ended | ||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||
Fair value of awards vested | $ |
|
$ |
|
||||
Cash paid |
|
|
(Units in thousands) |
Number of
Units |
Weighted-
Average Grant Date Fair Value |
||||||
Outstanding at December 31, 2022, nonvested |
|
$ |
|
|||||
Granted |
|
|
||||||
Outstanding at April 1, 2023, nonvested |
|
$ |
|
Three Months Ended | ||||||||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||||||||
Pension Benefits | ||||||||||||||
Service cost | $ |
|
$ |
|
||||||||||
Interest cost |
|
|
||||||||||||
Expected return on plan assets |
(
|
(
|
||||||||||||
Amortization of net actuarial loss |
|
|
||||||||||||
Amortization of prior service cost |
|
|
||||||||||||
Net periodic benefit income* | $ |
(
|
$ |
(
|
||||||||||
Postretirement Benefits Other Than Pensions | ||||||||||||||
Service cost | $ |
|
$ |
|
||||||||||
Interest cost |
|
|
||||||||||||
Amortization of net actuarial gain |
(
|
(
|
||||||||||||
Amortization of prior service credit |
(
|
(
|
||||||||||||
Net periodic benefit income | $ |
(
|
$ |
|
Three Months Ended | ||||||||||||||||||||
(Dollars in millions) |
April 1,
2023 |
April 2,
2022 |
% Change | |||||||||||||||||
Revenues | $ | 3,024 | $ | 3,001 | 1% | |||||||||||||||
Cost of sales | 2,531 | 2,492 | 2% | |||||||||||||||||
Gross margin as a % of Manufacturing revenues | 16.0% | 16.5% | ||||||||||||||||||
Selling and administrative expense | 305 | 305 | —% |
(In millions) |
April 1,
2023 |
December 31,
2022 |
||||||
Textron Aviation | $ | 6,523 | $ | 6,387 | ||||
Bell | 4,586 | 4,781 | ||||||
Textron Systems | 2,030 | 2,098 | ||||||
Total backlog | $ | 13,139 | $ | 13,266 |
Three Months Ended | ||||||||||||||||||||
(Dollars in millions) |
April 1,
2023 |
April 2,
2022 |
% Change | |||||||||||||||||
Revenues: | ||||||||||||||||||||
Aircraft | $ | 718 | $ | 646 | 11% | |||||||||||||||
Aftermarket parts and services | 431 | 394 | 9% | |||||||||||||||||
Total revenues | 1,149 | 1,040 | 10% | |||||||||||||||||
Operating expenses | 1,024 | 930 | 10% | |||||||||||||||||
Segment profit | $ | 125 | $ | 110 | 14% | |||||||||||||||
Profit margin | 10.9% | 10.6% |
(In millions) |
Q1 2023
versus Q1 2022 |
|||||||
Pricing | $ | 58 | ||||||
Volume and mix | 51 | |||||||
Total change | $ | 109 |
(In millions) |
Q1 2023
versus Q1 2022 |
|||||||
Pricing, net of inflation | $ | 17 | ||||||
Volume and mix | 15 | |||||||
Performance | (17) | |||||||
Total change | $ | 15 |
Three Months Ended | ||||||||||||||||||||
(Dollars in millions) |
April 1,
2023 |
April 2,
2022 |
% Change | |||||||||||||||||
Revenues: | ||||||||||||||||||||
Military aircraft and support programs | $ | 385 | $ | 597 | (36)% | |||||||||||||||
Commercial helicopters, parts and services | 236 | 237 | —% | |||||||||||||||||
Total revenues | 621 | 834 | (26)% | |||||||||||||||||
Operating expenses | 561 | 743 | (24)% | |||||||||||||||||
Segment profit | $ | 60 | $ | 91 | (34)% | |||||||||||||||
Profit margin | 9.7% | 10.9% |
(In millions) |
Q1 2023
versus Q1 2022 |
|||||||
Volume and mix | $ | (225) | ||||||
Pricing | 12 | |||||||
Total change | $ | (213) |
(In millions) |
Q1 2023
versus Q1 2022 |
|||||||
Volume and mix | $ | (61) | ||||||
Performance | 29 | |||||||
Pricing, net of inflation | 1 | |||||||
Total change | $ | (31) |
Three Months Ended | ||||||||||||||||||||
(Dollars in millions) |
April 1,
2023 |
April 2,
2022 |
% Change | |||||||||||||||||
Revenues | $ | 306 | $ | 273 | 12% | |||||||||||||||
Operating expenses | 272 | 245 | 11% | |||||||||||||||||
Segment profit | $ | 34 | $ | 28 | 21% | |||||||||||||||
Profit margin | 11.1% | 10.3% |
(In millions) |
Q1 2023
versus Q1 2022 |
|||||||
Volume | $ | 28 | ||||||
Pricing | 5 | |||||||
Total change | $ | 33 |
(In millions) |
Q1 2023
versus Q1 2022 |
|||||||
Performance | $ | 6 | ||||||
Pricing, net of inflation | 2 | |||||||
Volume and mix | (2) | |||||||
Total change | $ | 6 |
Three Months Ended | ||||||||||||||||||||
(Dollars in millions) |
April 1,
2023 |
April 2,
2022 |
% Change | |||||||||||||||||
Revenues: | ||||||||||||||||||||
Fuel systems and functional components | $ | 488 | $ | 464 | 5% | |||||||||||||||
Specialized vehicles | 444 | 374 | 19% | |||||||||||||||||
Total revenues | 932 | 838 | 11% | |||||||||||||||||
Operating expenses | 891 | 799 | 12% | |||||||||||||||||
Segment profit | $ | 41 | $ | 39 | 5% | |||||||||||||||
Profit margin | 4.4% | 4.7% |
(In millions) |
Q1 2023
versus Q1 2022 |
|||||||
Volume and mix | $ | 88 | ||||||
Pricing | 24 | |||||||
Foreign exchange | (18) | |||||||
Total change | $ | 94 |
(In millions) |
Q1 2023
versus Q1 2022 |
|||||||
Volume and mix | $ | 8 | ||||||
Pricing, net of inflation | 8 | |||||||
Performance | (12) | |||||||
Foreign exchange | (2) | |||||||
Total change | $ | 2 |
Three Months Ended | ||||||||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||||||||
Revenues | $ | 12 | $ | 16 | ||||||||||
Segment profit | 8 | 9 |
(Dollars in millions) |
April 1,
2023 |
December 31,
2022 |
||||||
Finance receivables | $ | 577 | $ | 587 | ||||
Allowance for credit losses | 22 | 24 | ||||||
Ratio of allowance for credit losses to finance receivables | 3.81% | 4.09% | ||||||
Nonaccrual finance receivables | 39 | 46 | ||||||
Ratio of nonaccrual finance receivables to finance receivables | 6.76% | 7.84% | ||||||
60+ days contractual delinquency | 2 | 1 | ||||||
60+ days contractual delinquency as a percentage of finance receivables | 0.35% | 0.17% |
(Dollars in millions) |
April 1,
2023 |
December 31,
2022 |
||||||
Manufacturing group | ||||||||
Cash and equivalents | $ | 1,719 | $ | 1,963 | ||||
Debt | 3,183 | 3,182 | ||||||
Shareholders’ equity | 7,008 | 7,113 | ||||||
Capital (debt plus shareholders’ equity) | 10,191 | 10,295 | ||||||
Net debt (net of cash and equivalents) to capital | 17% | 15% | ||||||
Debt to capital | 31% | 31% | ||||||
Finance group | ||||||||
Cash and equivalents | $ | 80 | $ | 72 | ||||
Debt | 367 | 375 |
Three Months Ended | ||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||
Operating activities | $ | 153 | $ | 225 | ||||
Investing activities | (42) | (28) | ||||||
Financing activities | (361) | (139) |
Three Months Ended | ||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||
Operating activities | $ | 4 | $ | (2) | ||||
Investing activities | 19 | 74 | ||||||
Financing activities | (15) | (119) |
Three Months Ended | ||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||
Operating activities | $ | 163 | $ | 241 | ||||
Investing activities | (29) | 28 | ||||||
Financing activities | (376) | (258) |
Three Months Ended | ||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||
Reclassification adjustments from investing activities to operating activities: | ||||||||
Cash received from customers | $ | 23 | $ | 27 | ||||
Finance receivable originations for Manufacturing group inventory sales | (17) | (9) | ||||||
Total reclassification adjustments from investing activities to operating activities | $ | 6 | $ | 18 |
Three Months Ended | ||||||||||||||
(In millions) |
April 1,
2023 |
April 2,
2022 |
||||||||||||
Gross favorable | $ | 25 | $ | 16 | ||||||||||
Gross unfavorable | (17) | (33) | ||||||||||||
Net adjustments | $ | 8 | $ | (17) |
Period (shares in thousands) |
Total
Number of Shares Purchased * |
Average Price
Paid per Share (excluding commissions) |
Total Number of
Shares Purchased as part of Publicly Announced Plan * |
Maximum
Number of Shares that may yet be Purchased under the Plan |
||||||||||
January 1, 2023 – February 4, 2023 | 1,225 | $ | 71.88 | 1,225 | 10,700 | |||||||||
February 5, 2023 – March 4, 2023 | 2,390 | 74.20 | 2,390 | 8,310 | ||||||||||
March 5, 2023 – April 1, 2023 | 1,615 | 69.25 | 1,615 | 6,695 | ||||||||||
Total | 5,230 | $ | 72.13 | 5,230 |
For | Against | Abstain | Broker Non-Vote | |||||||||||
Scott C. Donnelly | 170,203,230 | 5,402,155 | 782,661 | 10,509,196 | ||||||||||
Richard F. Ambrose | 172,863,817 | 2,583,789 | 940,440 | 10,509,196 | ||||||||||
Kathleen M. Bader | 169,609,009 | 5,899,256 | 879,781 | 10,509,196 | ||||||||||
R. Kerry Clark | 168,124,131 | 7,232,685 | 1,031,230 | 10,509,196 | ||||||||||
Deborah Lee James | 171,356,525 | 4,095,813 | 935,708 | 10,509,196 | ||||||||||
Thomas A. Kennedy | 172,906,906 | 2,489,521 | 991,619 | 10,509,196 | ||||||||||
Lionel L. Nowell III | 171,348,086 | 4,014,132 | 1,025,828 | 10,509,196 | ||||||||||
James L. Ziemer | 168,465,523 | 6,893,648 | 1,028,875 | 10,509,196 | ||||||||||
Maria T. Zuber | 170,486,969 | 4,984,241 | 916,836 | 10,509,196 |
For | Against | Abstain | Broker Non-Vote | ||||||||
166,367,179 | 8,966,312 | 1,054,555 | 10,509,196 | ||||||||
1 Year | 2 Years | 3 Years | Abstain | Broker Non-Vote | ||||||||||
170,243,524 | 930,467 | 4,542,787 | 671,268 | 10,509,196 | ||||||||||
For | Against | Abstain | ||||||
180,175,462 | 5,964,823 | 756,957 | ||||||
31.1 | |||||
31.2 | |||||
32.1 | |||||
32.2 | |||||
101 |
The following materials from Textron Inc.’s Quarterly Report on Form 10-Q for the quarterly period ended April 1, 2023, formatted in XBRL (eXtensible Business Reporting Language): (i) the Consolidated Statements of Operations, (ii) the Consolidated Statements of Comprehensive Income, (iii) the Consolidated Balance Sheets, (iv) the Consolidated Statements of Cash Flows and (v) the Notes to the Consolidated Financial Statements.
|
||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
TEXTRON INC. | |||||||||||
Date: | April 27, 2023 | /s/ Mark S. Bamford | |||||||||
Mark S. Bamford
Vice President and Corporate Controller (principal accounting officer) |
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
Customers
Customer name | Ticker |
---|---|
American Water Works Company, Inc. | AWK |
Southwest Airlines Co. | LUV |
Suppliers
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|